BONA, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 688
EU - Europa 287
AS - Asia 240
OC - Oceania 6
AF - Africa 4
SA - Sud America 4
Totale 1.229
Nazione #
US - Stati Uniti d'America 686
IT - Italia 128
SG - Singapore 102
CN - Cina 79
SE - Svezia 51
IE - Irlanda 44
DE - Germania 14
FI - Finlandia 13
UA - Ucraina 9
FR - Francia 8
JP - Giappone 8
KR - Corea 8
HK - Hong Kong 7
TR - Turchia 7
AU - Australia 6
IN - India 6
UZ - Uzbekistan 5
ID - Indonesia 4
PH - Filippine 4
VN - Vietnam 4
BR - Brasile 3
GR - Grecia 3
OM - Oman 3
RU - Federazione Russa 3
BE - Belgio 2
CA - Canada 2
CH - Svizzera 2
CI - Costa d'Avorio 2
CZ - Repubblica Ceca 2
ES - Italia 2
IL - Israele 2
NL - Olanda 2
PL - Polonia 2
EC - Ecuador 1
GB - Regno Unito 1
LT - Lituania 1
MA - Marocco 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 1.229
Città #
Chandler 137
Santa Clara 100
Singapore 93
Dublin 44
Ashburn 39
Turin 33
Nyköping 26
Columbus 21
Beijing 19
Fairfield 15
Medford 15
Torino 13
Princeton 12
Hangzhou 11
Los Angeles 10
Ann Arbor 9
Wilmington 9
Helsinki 8
Rome 7
Seoul 7
Cambridge 6
Guangzhou 6
Houston 6
Milan 6
Redwood City 6
Seattle 6
Woodbridge 6
Boston 5
Dearborn 5
Hebei 5
Istanbul 5
New York 5
Chengdu 4
Jacksonville 4
Jakarta 4
Nichelino 4
San Mateo 4
Sydney 4
Albignasego 3
Alessandria 3
Buffalo 3
Changsha 3
Chicago 3
Dong Ket 3
Hong Kong 3
Lappeenranta 3
Muscat 3
Stockholm 3
Verona 3
Villeurbanne 3
Abidjan 2
Athens 2
Boardman 2
Brno 2
Brussels 2
Böblingen 2
Charleston 2
Chongqing 2
Desio 2
Fremont 2
Gioia del Colle 2
Guiyang 2
Konya 2
Kunming 2
La Tour-de-Peilz 2
Las Vegas 2
Madrid 2
Messina 2
Mumbai 2
Nishikicho 2
Novara 2
Ostfildern 2
Paris 2
Perth 2
Petriolo 2
Piemonte 2
Pune 2
Shiyan 2
St Petersburg 2
Stuttgart 2
Tel Aviv 2
Toronto 2
Waghäusel 2
Absecon 1
Americana 1
Bari 1
Bologna 1
Bronx 1
Central District 1
Châtillon 1
Cochin 1
Dandong 1
Falls Church 1
Fukuoka 1
Geldern 1
Ichibacho 1
Indiana 1
Jinan 1
Katy 1
Lama Mocogno 1
Totale 838
Nome #
HLA DRB1*0415: a new possible genetic susceptibility factor for Hirata's disease 209
Testosterone as a Biomarker of Adverse Clinical Outcomes in SARS-CoV-2 Pneumonia 93
Retrospective observational analysis of non-irradiated non-functioning pituitary adenomas 83
Untreated adult GH deficiency is not associated with the development of metabolic risk factors: a long-term observational study 81
Acromegaly and joint pain: is there something more? A cross-sectional study to evaluate rheumatic disorders in growth hormone secreting tumor patients 74
Biliary adverse events in acromegaly during somatostatin receptor ligands: predictors of onset and response to ursodeoxycholic acid treatment 68
Second-Day Morning Cortisol Levels after Transsphenoidal Surgery Are Accurate Predictors of Secondary Adrenal Insufficiency with Diagnostic Cut-Offs Similar to Those in Non-Stressed Conditions 62
MORNING SERUM CORTISOL LEVEL PREDICTS CENTRAL ADRENAL INSUFFICIENCY DIAGNOSED BY INSULIN TOLERANCE TEST 57
Diabetic ketoacidosis in acromegaly: a case study—somatostatin analogs adverse event or disease complication? 55
Optimal timing of blood samplings to detect GH inhibition during oral glucose tolerance test 53
Primary pituitary lymphoma as rare cause of a pituitary mass and hypopituitarism in adulthood 52
The prevalence of silent acromegaly in prolactinomas is very low 47
Adrenocortical, somatotropic, and antidiuretic response to nasal glucagon in healthy subjects. 45
Copeptin adaptive response to SGLT2 inhibitors in patients with type 2 diabetes mellitus: The GliRACo study 44
Neuroendocrine response to diclofenac in healthy subjects: a pilot study. 37
Mean GH profile is more accurate than single fasting GH in the evaluation of acromegaly disease control during somatostatin receptor ligands therapy 37
Development and internal validation of a predictive score for the diagnosis of central adrenal insufficiency when morning cortisol is in the grey zone 36
Psychiatric disorders and anger in patients with controlled acromegaly 33
MRI Assessment of Cardiac Function and Morphology in Adult Patients With Growth Hormone Deficiency: A Systematic Review and Meta-Analysis 27
Markers of Aggressiveness in Pituitary Tumors: Update and Perspectives 26
GHRH + arginine test and body mass index: do we need to review diagnostic criteria for GH deficiency? 25
Isolated anterior pituitary dysfunction in adulthood 22
null 12
Effect of Cabergoline on weight and glucose metabolism in patients with acromegaly. 10
Prolactin-secreting tumors, dopamine agonists and pregnancy: a longitudinal experience of a tertiary neuroendocrine center 6
Totale 1.294
Categoria #
all - tutte 6.996
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.996


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202023 0 0 0 0 0 0 3 7 4 4 3 2
2020/2021123 2 9 5 6 21 7 24 16 10 1 5 17
2021/2022184 5 8 11 7 10 15 10 8 11 22 41 36
2022/2023377 27 36 5 39 34 75 13 16 49 27 33 23
2023/2024226 24 36 13 14 12 21 19 41 1 18 7 20
2024/2025327 8 46 11 70 137 53 2 0 0 0 0 0
Totale 1.294